Wow, there was that heart abstract from the researchers in Toronto. It read great. A few days ago anpther TB 4 and heart abstract hit. from researchers in Chona. They used 190 HUMAN patients....they were measuring coronary stenosis....they took 103 humans..who exhibited worse coronary stenosis...and they too 87 humans with coronary stenosis who were better off. Both groups had issues. What they found was that the 87 patients with less issues of coronary stenosis - had significantly higher amounts of TB 4 exhibited. The 103 patients wil worse coronary issues had markedly LOWer levels of inate TB 4.
Id like to know when RGRX is going tp do something with all this ncredible research. And I think shareholders deserve to know exactly what is covered in the issued 2007 patent by USPO
This abstract reads very well. It wasn't in mice or a petri dish. Humans.:
Oh, also notice on the above link....we are the lead article.
It is remarkabe how our mgmt is so good at making ssure no one knows about things like this. Even if RGRX didn't sponsor the work, why the <<<F>>> don't they tell anyone...point an analyst to it. Just do SOMETHING rather than sit on your butts and wait for the next necessary PIPE deal.